Yahoo Web Search

  1. Yahoo Finance Results

  2. This could indicate that investors who seek to profit from falling equity prices are not currently targeting PFE. Index (PMI) data, output in the Healthcare sector is rising.

  3. Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity

    Zacks via Yahoo FinanceNov 28 22:09 PM

    Pfizer Inc. PFE announced that the FDA has granted pediatric exclusivity to its epilepsy drug, Lyrica. The pediatric exclusivity was granted based on data from Lyrica Pediatric ...

    44.16+0.15 (+0.34%)

    at Wed, Dec 12, 2018, 16:00PM EST - U.S. Markets open in 7 hrs 27 mins

    After Hours 44.07 -0.09 (-0.20%)

    Delayed Quote

    • Open 44.35
    • High 44.85
    • Low 44.15
    • 52 Wk. High 46.47
    • 52 Wk. Low 33.20
    • Mkt. Cap 255.27B
  4. We would like to remind investors that this is the fourth cancer medicine nod for Pfizer in less than three months Earlier this month, Pfizer gained the FDA’s accelerated approval ...

  5. Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP) Avanos Medical In (NYSE: AVNS) Aptevo Therapeutics Inc (NASDAQ: APVO) Aquestive Therapeutics Inc (NASDAQ: AQST) Biocept Inc ...

  6. CVX and Pfizer Inc. PFE. The Dow traversed a particularly difficult holiday-shortened week.

  7. It has been about a month since the last earnings report for Pfizer (PFE). Will the recent positive trend continue leading up to its next earnings release, or is Pfizer due for ...

  8. 4 Big Pharma Stocks to Add to Your Portfolio in December

    Zacks via Yahoo FinanceNov 29 13:10 PM

    Large –Cap Pharma and Biomed/Genetics Versus S&P 500 The Large-Cap Pharmaceuticals industry features among the top 30% of the 255 Zacks-ranked industries We believe that strong quarterly results ...

  9. Recap of the Week’s Most Important Stories Pfizer Gets FDA Nod for Rare Cancer Medicine: The FDA granted approval to Daurismo for a rare blood cancer, Pfizer’s fourth cancer medicine ...

  10. Pfizer (PFE) Gains But Lags Market: What You Should Know

    Zacks via Yahoo FinanceNov 28 22:45 PM

    Pfizer (PFE) closed the most recent trading day at $44.90, moving +1.88% from the previous trading session. In that same time, the Medical sector gained 3.55%, while the S&P 500 gained ...

  11. Recap of the Week’s Most Important Stories Pfizer Gets FDA Nod for Rare Cancer Medicine: The FDA granted approval to Daurismo for a rare blood cancer, Pfizer’s fourth cancer medicine ...